Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS study
- PMID: 38001335
- PMCID: PMC11162596
- DOI: 10.1007/s10552-023-01834-4
Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS study
Abstract
Purpose: This study aimed to evaluate the association of race/ethnicity, patient care experiences (PCEs), and receipt of definitive treatment and treatment modality among older adults in the United States (US) with localized prostate cancer (PCa).
Methods: Using Surveillance, Epidemiology and End Results dataset linked to Medicare Consumer Assessment of Healthcare Providers and Systems (SEER-CAHPS) for 2007-2015, we identified men aged ≥ 65 years who completed a CAHPS survey within one year before and one year after PCa diagnosis. Associations of race/ethnicity (non-Hispanic White (NHW), non-Hispanic Black (NHB), Hispanic, non-Hispanic Asian (NHA), and other) and of interactions between race/ethnicity and PCEs (getting needed care, getting care quickly, doctor communication, and care coordination) with the receipt of definitive PCa treatment and treatment modality within 3 and 6 months of diagnosis were examined using logistic regressions.
Results: Among 1,438 PCa survivors, no racial/ethnic disparities in the receipt of definitive treatment were identified. However, NHB patients were less likely to receive surgery (vs. radiation) within 3 and 6 months of PCa diagnosis than NHW patients (OR 0.397, p = 0.006 and OR 0.419, p = 0.005), respectively. Among NHA patients, a 1-point higher score for getting care quickly was associated with lower odds (OR 0.981, p = 0.043) of receiving definitive treatment within 3 months of PCa diagnosis, whereas among NHB patients, a 1-point higher score for doctor communication was associated with higher odds (OR 1.023, p = 0.039) of receiving definitive treatment within 6 months of PCa diagnosis.
Discussion: We observed differential associations between PCEs and receipt of definitive treatment based on patient race/ethnicity. Further research is needed to explore these associations.
Keywords: CAHPS; Care experiences; Communication; Disparities; Prostate cancer (PCa); SEER.
© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Conflicts of interest
The authors have no conflicts of interests to declare. CL received research support for unrelated projects sponsored by University of Utah/AstraZeneca.
Similar articles
-
Association of race/ethnicity and patient care experiences with healthcare utilization and healthcare costs among prostate cancer survivors: A SEER-CAHPS study.J Geriatr Oncol. 2024 Apr;15(3):101748. doi: 10.1016/j.jgo.2024.101748. Epub 2024 Mar 16. J Geriatr Oncol. 2024. PMID: 38493533
-
Differences in racial/ethnic disparities in patient care experiences between prostate cancer survivors and males without cancer: A SEER-CAHPS study.J Geriatr Oncol. 2023 Jul;14(6):101554. doi: 10.1016/j.jgo.2023.101554. Epub 2023 Jun 13. J Geriatr Oncol. 2023. PMID: 37320932 Free PMC article.
-
Racial/Ethnic Disparities in Patient Care Experiences among Prostate Cancer Survivors: A SEER-CAHPS Study.Curr Oncol. 2022 Nov 1;29(11):8357-8373. doi: 10.3390/curroncol29110659. Curr Oncol. 2022. PMID: 36354719 Free PMC article.
-
Associations between race/ethnicity and SEER-CAHPS patient care experiences among female Medicare beneficiaries with breast cancer.J Geriatr Oncol. 2023 Nov;14(8):101633. doi: 10.1016/j.jgo.2023.101633. Epub 2023 Sep 22. J Geriatr Oncol. 2023. PMID: 37741036 Free PMC article.
-
Sociodemographic disparities in prostate cancer imaging.Abdom Radiol (NY). 2024 Sep 26. doi: 10.1007/s00261-024-04603-2. Online ahead of print. Abdom Radiol (NY). 2024. PMID: 39325212 Review.
References
-
- Surveillance Epidemiology and End Results (SEER). (2021). Prostate Cancer - Cancer Stat Facts. Retrieved October 4, 2022, from https://seer.cancer.gov/statfacts/html/prost.html
-
- D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, … Wein A (1998). Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer. JAMA, 280(11), 969–974. 10.1001/JAMA.280.11.969 - DOI - PubMed
-
- National Cancer Institute. (2021). Prostate Cancer Treatment (PDQ®)–Health Professional Version - National Cancer Institute. Retrieved September 2, 2021, from https://www.cancer.gov/types/prostate/hp/prostate-treatment-pdq
-
- American Urological Association (AUA) / American Society for Radiation Oncology (ASTRO) / Society of Urologic Oncology (SUO), & American Urological Association. (2017). Prostate Cancer: Clinically Localized Guideline - American Urological Association. Retrieved September 2, 2021, from https://www.auanet.org/guidelines/guidelines/prostate-cancer-clinically-...
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
